SUCROSOMIAL TECHNOLOGY

A unique delivery system, a revolution in the field of nutraceuticals, which guarantees maximum efficacy in transporting and absorbing essential bioactive compounds.

CETYLATED FATTY ACIDS

A patented solution designed to enhance joint and muscle mobility, known for its exceptional skin penetration and rapid absorption.

PRODUCTS

PharmaNutra products are designed to provide a safe and effective response to health and well-being requirements at any stage of life.
R&D

We are committed to advancing nutraceutical science by developing effective, high-quality supplements and medical devices.

In our laboratories, we use cutting-edge research models to drive innovation, blending solid scientific methods with a forward-thinking approach to technology and patents. PharmaNutra's research focuses on key health areas, especially addressing nutritional deficiencies in minerals and vitamins, supporting muscle and joint health and enhancing functional and sports nutrition.

MORE
THERAPEUTIC AREAS

Our scientific research

NEWS

Inform, innovate, inspire: putting health first

Stay updated with the latest from PharmaNutra: scientific insights, events, groundbreaking products and updates tailored to support your professional practice.
News & Events

PharmaNutra sponsors Pisa Sporting Club again for 2021-2022

Read more
Iron deficiency

ASH Atlanta 2017: a success for SiderAL® brand

Read more
News & Events

STAR Conference Fall Edition 2021: PharmaNutra meets with analysts and investors

Read more
Raw materials

Vitafoods 2024: Alesco aims to increase the international network

Read more
News & Events

Cetilar® at Cariparma Running

Read more
Minerals and vitamins

Sleep disorders: why magnesium can help us sleep better

Read more
Iron deficiency

Iron deficiency, an increasingly female disorder?

Read more
News & Events

PharmaNutra confirms its sponsorship of SANIS 2025

Read more
Raw materials

UltraChrome®: Sucrosomial® Chromium that supports the metabolism and glycaemic control

Read more
News & Events

CPhI North America 2022: Philadelphia, 17-19 May

Read more
Raw materials

News 2021: Sucrosomial® Berberine and Sucrosomial® Chromium

Read more
Iron deficiency

New scientific studies on Sucrosomial® Technology applied to iron

Read more
Raw materials

Alesco-PharmaNutra Merger: from July 2024, Alesco will become a business division of the Group

Read more
News & Events

PharmaNutra participates in the second edition of Mediobanca’s Italian Mid Cap Conference

Read more
News & Events

STAR Conference Spring Edition 2021: PharmaNutra meets investors following its first STAR year

Read more